The GDG felt that it was important that men with LUTS should be given information on their condition and management options. A specific recommendation was not formulated as this topic is adequately covered in the introduction of the NICE guideline.
Relative values of different outcomesThe GDG considered an improvement in their symptoms and quality of life to be the primary outcomes. The quality of life reported was from the IPSS symptom score questionnaire. However, incontinence is one important quality of life factor that is not recorded by IPSS.
Trade off between clinical benefits and harmsThe GDG considered it important that patients are fully aware of their condition and its management. The harm associated with lack of information and subsequent understanding could be increased anxiety and low compliance of medications.
Economic considerationsA study showed that providing interactive multimedia programmes increases costs with no significantly different outcome. However, this intervention does not reflect the clinical practice where other means of provision of information are adopted, which can improve outcomes or patient satisfaction without increasing costs to the NHS.
Quality of evidenceAll three clinical studies were of moderate quality due to a lack of precision.

The economic evidence has minor limitations but partial applicability as the intervention considered does not reflect the clinical practice.
Other considerationsThe interactive programmes did not result in a significant improvement in symptoms and the GDG felt it was more appropriate to recommend general provision of information rather than specific techniques.

From: 15, Provision of information to, and support of, patients

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.